Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New knowledge in primary biliary cirrhosis

M E Gershwin1, I R Mackay

  • 1School of Medicine, University of California, Davis, USA.

Hospital Practice (1995)
|August 15, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Levels of BAFF in serum in primary biliary cirrhosis and autoimmune diabetes.

Autoimmunity·2003
Same author

Humanism and the suffering of the people.

Internal medicine journal·2003
Same author

Autoantibodies to the islet cell antigen SOX-13 are associated with duration but not type of diabetes.

Diabetic medicine : a journal of the British Diabetic Association·2003
Same author

A dietary cause of type 1 diabetes: unearthing a new twist to the tale.

Diabetes technology & therapeutics·2002
Same author

Antimitochondrial autoantibodies in saliva and sera from patients with primary biliary cirrhosis.

Journal of gastroenterology and hepatology·2002
Same author

Dietary microbial toxins and type 1 diabetes--a new meaning for seed and soil.

Diabetologia·2001
Same journal

A rocking biologic prosthetic valve: <i>Cutibacterium acnes</i> prosthetic valve endocarditis.

Hospital practice (1995)·2026
Same journal

Diagnostic accuracy of the Wells score versus duplex ultrasound for deep vein thrombosis in a Ghanaian cohort.

Hospital practice (1995)·2026
Same journal

Examining the frequency and factors related to the occurrence of deep vein thrombosis (DVT) in patients undergoing posterior fixation of the lumbosacral spine (PSF).

Hospital practice (1995)·2025
Same journal

The impact of hospitalist experience on patient outcomes: a retrospective cohort analysis at an academic medical center.

Hospital practice (1995)·2025
Same journal

The efficacy of melatonin as a preoperative anxiolytic in real-world setting: a randomized controlled trial.

Hospital practice (1995)·2025
Same journal

Antibiotic prescription patterns among hospitalized patients with influenza: a cross-sectional study in a tertiary referral hospital in Iran.

Hospital practice (1995)·2025
See all related articles

Autoantibodies target essential mitochondrial enzymes, yet this autoimmune disease specifically attacks liver bile ducts. This tissue-specific attack may be triggered by cell-surface antigens unique to bile duct cells.

Area of Science:

  • Immunology
  • Hepatology
  • Cell Biology

Background:

  • Autoimmune diseases involve the immune system mistakenly attacking the body's own tissues.
  • Mitochondrial enzymes are crucial for cellular energy production across all cell types.
  • Primary biliary cholangitis (PBC) is an autoimmune liver disease characterized by damage to intrahepatic bile ducts.

Observation:

  • The autoantibodies in this disease target mitochondrial enzymes vital for cellular function.
  • Despite the ubiquitous nature of these enzymes, the disease predominantly affects the epithelial cells of intrahepatic bile ductules.
  • This suggests a localized trigger or target within the liver.

Findings:

  • The characteristic autoantibodies react against mitochondrial enzymes.

Related Experiment Videos

  • The disease's specific targeting of intrahepatic bile ductule epithelial cells points to a tissue-specific phenomenon.
  • A potential explanation involves the cell-surface expression of a triggering antigen unique to these bile duct cells.

    • Implications:

    • Understanding the tissue specificity could reveal novel therapeutic targets for autoimmune liver diseases.
    • Identifying the triggering antigen may elucidate the pathogenesis of bile duct destruction.
    • This research could lead to more accurate diagnostic markers and targeted treatments for patients with this condition.